“At 36 weeks, I started feeling itchy hands and feet. I lotioned, ignored it, but it kept getting worse. I kept thinking of ...

The rate of Americans diagnosed with digestive disorders and gastrointestinal cancers is rising, especially in those ages 50 ...

Following successful studies, the National Institute of Health and Care Excellence (NICE) has recommended a new drug for ...

Still given JNJ has most of the rights to market and sell icontrokinra, is there any pressing need to complete a full, ...

The rollout of a drug recommended by the National Institute of Health and Care Excellence is 'really exciting' news for UK ...

A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.

Medical digital twins are computerised versions of patients, enabling different treatments to be tested and the most ...

Kenny Wallace provided a health update on his longtime friend and crew member, Frankie 'Jughead' Rawlins. The Cup Series ...

Q3 2025 Earnings Call Transcript October 14, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, ...

Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom ...

Around one in 650 people in the UK suffer from Crohn's disease, but now a new medication has given them hope after being ...

Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in ...